Structure of p53 103-111 (HLA-A*02:01)
Logo for Cancer
Cancer

p53 103-111 (HLA-A*02:01) YLGSYGFRL

€210.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP11386_5

Description

YLGSYGFRL is a linear peptidic epitope (epitope ID74682), tested in T cell assays. The peptide p53 103-111 (HLA-A*02:01) recognizes CD8 T cells, and can be used in the analysis of individual antigen-specific T cells.

TechData

Sequence: YLGSYGFRL
Gene: TP53
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Cellular tumor antigen p53
Species: Human
Allele: HLA-A*02:01
Application: Flow Cytometry
Indication: Cancer
Purity: 95% HPLC-MS
Skip product gallery

More p53 peptides

p53 139-147 (HLA-A*02:01)
p53-derived peptide of KLCPVQLWV sequence covering 139-147 and HLA-A*02:01 molecule. The peptide p53 139-147 (HLA-A*02:01) recognizes human CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. KLCPVQLWV is a linear peptidic epitope (epitope ID31776). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
p53 149-157 (HLA-A*02:01)
SLPPPGTRV is a linear peptidic epitope (epitope ID59401). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
p53 149–157 mutant (HLA-A*02:01) 150T
STPPPGTRV is a linear peptidic epitope (epitope ID61832) studied as part of Cellular tumor antigen p53 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
p53 187-197 (HLA-A*02:01)
p53-derived peptide of GLAPPQHLIRV sequence covering 187-197 and HLA-A*02:01) molecule. The peptide p53 187-197 recognizes human CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. GLAPPQHLIRV is a linear peptidic epitope (epitope ID20767) studied as part of Cellular tumor antigen p53 from Homo sapiens (human) and Cellular tumor antigen p53 from Otospermophilus beecheyi (California ground squirrel). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
p53 264-272 (HLA-A*0201)
Single peptide LLGRNSFEV for stimulation of p53 (264-272)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Targeting diseases are cancer, allergies, viral infections and autoimmune disorders.

From €105.00*
p53 65-73 (HLA-A*02:01)
RMPEAAPPV is a linear peptidic epitope (epitope ID54934) studied as part of Cellular tumor antigen p53 from Homo sapiens (human) and Tupaia belangeri (common tree shrew) protein from Tupaia belangeri (common tree shrew). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays. The peptide p53 65-73 (HLA-A*02:01) recognizes CD8 T cells, and can be used in the analysis of individual antigen-specific T cells.

From €105.00*